Clinical Trial Update: A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing atomoxetine with standard care in children and adolescents with ADHD to assess long-term functioning; trial completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Strattera (atomoxetine) (atomoxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2010-04-20